Standout Papers

Assessment of Tocilizumab (Anti–Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chroni... 2017 2026 2020 2023 240
  1. Assessment of Tocilizumab (Anti–Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients (2017)
    Jua Choi, Ashley Vo et al. American Journal of Transplantation

Immediate Impact

27 standout
Sub-graph 1 of 11

Citing Papers

Periodontal disease: A systemic condition
2024 Standout
Glomerulonephritis: immunopathogenesis and immunotherapy
2023 Standout
3 intermediate papers

Works of A. Loupy being referenced

Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation
2018
Assessment of Tocilizumab (Anti–Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients
2017 Standout

Author Peers

Author Last Decade Papers Cites
A. Loupy 134 77 225 93 3 304
Sabrina Louie 114 48 190 103 7 278
Kristen Cisneros 122 75 251 131 5 322
Samir Boudjeltia 121 99 261 118 7 355
A Feroz 90 78 144 56 7 253
Odette A. Galera 116 22 137 86 8 321
Flavia Sequeira 173 106 301 178 8 365
Eduardo Mancilla Urrea 92 20 214 73 7 282
R. Castro 157 68 234 101 5 368
Katharine Spain 196 32 253 46 8 313
Rebecca Shi 91 19 240 101 8 342

All Works

Loading papers...

Rankless by CCL
2026